Wayne Mascarella

RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.

Search Publications

Filter by Year

Filter by Publication Type

Search Results

Sex-specific risk profiles for substance use among college students

Genetic stratification of depression by neuroticism: Revisiting a diagnostic tradition

Examination of a novel measure of trauma-related drinking to cope

Associations between ethnic-racial identity and alcohol problems among diverse emerging adults

Synthesis of [H-3] and [C-14]genipin

Host-agent-vector-environment measures for electronic cigarette research used in NIH grants

Does this patient still want a kidney transplant? Changing treatment preferences among African Americans on the kidney transplant waiting list

A unique formulation of cardioprotective bio-actives: An overview of their safety profile

Catching the whale: A comparison of place promotion strategies through the lens of Amazon HQ2

Adverse childhood events and risk of diabetes onset in the 1979 National longitudinal survey of youth cohort

Risks associated with mid-level cannabis use among people treated for alcohol Use disorder

Body mass index and type 2 collagen turnover in individuals after anterior cruciate ligament reconstruction

A randomized controlled laboratory study on the long-term effects of methylphenidate on cardiovascular function and structure in rhesus monkeys

Synthesis and characterization of the selective, reversible pkcβ inhibitor (9 s)-9-[(dimethylamino)methyl]-6,7,10,11-tetrahydro-9 h,18 h-5,21:12,17-dimethenodibenzo[ e,k]pyrrolo[3,4- h][1,4,13]oxadiazacyclohexadecine-18,20(19 h)-dione, ruboxistaurin (ly3

Streamlining nonclinical drug development using the FDA 505(b)(2) new drug application regulatory pathway

Potent and selective tetrahydroisoquinoline kappa opioid receptor antagonists of lead compound (3 R)- N-[1 R)-1-(Cyclohexylmethyl)-2-methylpropyl]-7-hydroxy-1,2,3,4-tetrahydroisoquinoline-3-carboxamide (CDTic)

Potent and selective tetrahydroisoquinoline kappa opioid receptor antagonists of lead compound (3r)-7-hydroxy-n-[(1s)-2-methyl-1-(piperidin-1-ylmethyl)propyl]-1,2,3,4-tetrahydroisoquinoline-3-carboxamide (pdtic)

Synthesis and physicochemical characterization of (6S)-5-formiminotetrahydrofolate; a reference standard for metabolomics

Medical device innovation: Capitalizing on the pace of change

Caged Naloxone: Synthesis, characterization, and stability of 3-O-(4,5-Dimethoxy-2-nitrophenyl)carboxymethyl Naloxone (CNV-NLX)